We welcome our new partner

Advancing personalized treatment after myocardial infarction

In the curAInfarct project, Prof. Dr. med. Eberhard Wieland and Lucia Thelen from Bioscientia Healthcare GmbH contribute their expertise in laboratory medicine and clinical diagnostics to the curATime consortium.

The project aims to improve our understanding of the biological processes following myocardial infarction and to support the development of more precise diagnostic and therapeutic approaches. Bioscientia’s experience in laboratory-based analyses and quality-assured diagnostic processes will help translate scientific findings into clinically relevant insights.

By connecting cardiovascular research with laboratory diagnostics, the collaboration contributes to the long-term goal of identifying individual disease patterns, assessing risks more accurately, and enabling more personalized care for patients after myocardial infarction.

We warmly welcome Bioscientia to the curATime consortium and look forward to jointly advancing innovative solutions for cardiovascular medicine.

New curATime publication

The systematic review by Aida Romano-Matinez from the working group of Philipp Wild from the University Medical Center Mainz and co-workers shows how AI could help automate echocardiographic analysis, streamline clinical workflows, and ultimately support more efficient cardiovascular care.

curATalk Christoph Sandmann - 17.11.2026

Cells of the Human Heart from Birth to Adulthood: Implications for Cardiac Regeneration

17.11.2026, 17 - 18

Dr. Dr. Christoph Sandmann

Research Fellow at Harvard Medical School, Boston, MA, USA

The seminar will be held on-site at University Medical Center Mainz, Seminar room 2, Building 708.

We are welcoming our new partners

In the curAIAlert project, Philipp Busch of Mind Games and Daniel Dürr, a cardiac surgeon at the University Medical Center Mainz, are collaborating on the development of an AI-powered wearable warning system for heart failure patients. By combining data from wearables, medical records, and patient-reported outcomes, the system aims to detect early signs of deterioration and enable timely interventions.

Drawing on its expertise in gamification and serious games, Mind Games will help create engaging features that promote treatment adherence and healthier lifestyles.

We warmly welcome Mind Games to the curATime consortium and look forward to jointly advancing innovative solutions for heart failure care.

curATalk Steffen Massberg - 29.09.2026

Crosstalk of immunity and thrombosis – novel targets for vascular disease and beyond

29.09.2026, 17 - 18

Prof. Dr. med. Steffen Massberg

Director of the Medical Clinic and Polyclinic I, LMU University Hospital, Munich

The seminar will be held on-site at University Medical Mainz, Seminar room 2, Building 708.

Successfull Kick-off event for the 2. phase

With the kick-off event on September 8, 2026, at DFKI in Kaiserslautern, we have officially launched the second funding phase. The event gave the partners the opportunity to introduce themselves, get to know the entire cluster, and thereby identify valuable synergies. The positive atmosphere and the in-depth discussions demonstrated how important close collaboration within the cluster—as well as a strong network—are for developing innovative solutions in cardiovascular medicine. We were particularly pleased to welcome Clemens Hoch, Minister of Science, Further Education, and Health for the State of Rhineland-Palatinate. We rounded off the successful day with a barbecue, which provided further opportunities for conversation, networking, and personal interaction.

curATime at leading scientific meetings in asia

As part of several international research visits, our Cluster Spokesman Johnny Kim presented current research findings in China and South Korea, while also highlighting the collaborative work of the curATime Cluster. At the 2026 KSSCR Annual Meeting in Seoul, he delivered a presentation entitled “Epigenetic Plasticity in Aging, Regeneration, and Disease.”

His contributions underline curATime’s growing international visibility and promote scientific exchange with researchers around the world.

Welcome to the team!

We are delighted to welcome a new member to the curATime team: Prof. Philipp Lurz, Director of the Center for Cardiology at University Medical Center Mainz, is now actively supporting the curASonic project: “curATime is more than just a cluster of excellence. curATime is creating an ecosystem of innovation in the Main-Rhine region and in Rhineland-Palatinate, which will enable us, working together as a team, to rethink and redesign treatment strategies for atherosclerosis! Personally, I will contribute my clinical expertise in the field of cardiovascular medicine and, from a scientific perspective, our clinical mechanistic models and approaches to reverse translation.”

We are welcoming our new partners

Upscaling for the successful production of cells for heart regeneration after myocardial infarction

In the project curARace, Boris Greber (Catalent), Robert Zweigerdt (MHH), and Johnny Kim (TRON) are collaborating to develop a scalable, GMP-compliant platform for the production of functional, transplantable cardiac cells and tissues derived from human iPS cells. By combining insights gained from curATime with Catalent’s extensive expertise in GMP-compliant manufacturing, gene editing, and quality control of cell products, the partners aim to advance innovative approaches for cardiac regeneration.

We warmly welcome Catalent to the consortium and look forward to jointly advancing next-generation solutions for heart tissue regeneration.

curATime Publication

Exciting news from our microbAIome project: A study by Nadja Paeslack from the group of Christoph Reinhardt has been published in the Redox Biology jounal, titled "Toll-like receptor 2 impacts small intestinal villus capillarization through epithelial dual oxidase 2".

The study identifies a novel microbiota–TLR2–DUOX2 signaling axis that regulates the vascularization of intestinal villi, the tiny structures responsible for nutrient absorption in the small intestine. The findings link microbial sensing in the gut epithelium to vascular remodeling during both homeostasis and inflammation.